Application update

RNS Number : 2357H
Xtract Resources plc
22 November 2022
 

 

For immediate release

 22 November 2022

Xtract Resources Plc

("Xtract" or the "Company")

             Application update

 

The Board of Xtract announces that application to trading on AIM on or around 29 November 2022 ("Admission") has now been made for  5,362,229  new Ordinary Shares issued at a price of 3.23p per Ordinary Share, issued in settlement of accrued outstanding remuneration in relation to 2021, due to certain Directors and employees of the Company ("Settlement Shares") and  the issue of 619,195 new Ordinary Shares ("Creditor Settlement Shares") issued at a price of 3.23p per Ordinary share, in aggregate amounting to 5,981,424 new Ordinary Shares ("New Shares"), as announced on 4 November 2022. The New Shares will rank pari passu in all respects with the Company's existing issued ordinary shares.

 

Total Voting Rights

On Admission, the Company's issued share capital consists of 856,375,115 ordinary shares of 0.02p each with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 856,375,115. The above figure of 856,375,115 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

A copy of this announcement:  www.xtractresources.com

 

Enquiries :

Xtract Resources Plc

Colin Bird,

Executive Chairman

 

+44 (0)20 3416 6471

www.xtractresources.com

Beaumont Cornish Limited

Nominated Adviser and Joint Broker

Roland Cornish

Michael Cornish

Felicity Geidt

+44 (0)207628 3369

www.beaumontcornish.co.uk

 

Novum Securities Limited

Joint Broker  

 

Jon Bellis

Colin Rowbury 

 

+44 (0) 207 399 9427

www.novumsecurities.com  

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGPGGUPPGPP
UK 100

Latest directors dealings